Huntington Nationwide Financial institution raised its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 17.9% within the third quarter, in response to its most up-to-date 13F submitting with the SEC. The fund owned 1,054 shares of the monetary providers supplier’s inventory after shopping for a further 160 shares through the interval. Huntington Nationwide Financial institution’s holdings in iShares Biotechnology ETF had been price $153,000 on the finish of the newest quarter.
A number of different institutional traders and hedge funds have additionally modified their holdings of the inventory. Most important Administration ETF Advisors LLC raised its place in iShares Biotechnology ETF by 2.6% through the second quarter. Most important Administration ETF Advisors LLC now owns 578,835 shares of the monetary providers supplier’s inventory valued at $79,451,000 after buying a further 14,535 shares within the final quarter. Raymond James Monetary Providers Advisors Inc. lifted its stake in shares of iShares Biotechnology ETF by 24.6% within the 2nd quarter. Raymond James Monetary Providers Advisors Inc. now owns 217,047 shares of the monetary providers supplier’s inventory valued at $29,792,000 after buying a further 42,822 shares through the interval. Raymond James & Associates boosted its holdings in iShares Biotechnology ETF by 4.4% through the second quarter. Raymond James & Associates now owns 189,766 shares of the monetary providers supplier’s inventory price $26,047,000 after shopping for a further 7,931 shares within the final quarter. Osaic Holdings Inc. grew its place in iShares Biotechnology ETF by 9.4% through the first quarter. Osaic Holdings Inc. now owns 160,173 shares of the monetary providers supplier’s inventory valued at $21,985,000 after shopping for a further 13,777 shares through the interval. Lastly, Albion Monetary Group UT grew its place in iShares Biotechnology ETF by 0.3% through the third quarter. Albion Monetary Group UT now owns 129,980 shares of the monetary providers supplier’s inventory valued at $18,925,000 after shopping for a further 356 shares through the interval. Institutional traders and hedge funds personal 62.45% of the corporate’s inventory.
iShares Biotechnology ETF Buying and selling Down 4.8 %
Shares of iShares Biotechnology ETF inventory opened at $133.38 on Monday. The agency has a 50-day easy shifting common of $144.49 and a two-hundred day easy shifting common of $141.78. iShares Biotechnology ETF has a fifty-two week low of $116.70 and a fifty-two week excessive of $150.57.
iShares Biotechnology ETF Publicizes Dividend
The agency additionally just lately declared a dividend, which was paid on Monday, September thirtieth. Traders of document on Wednesday, September twenty fifth had been issued a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September twenty fifth.
iShares Biotechnology ETF Profile
iShares Nasdaq Biotechnology ETF (the Fund), previously iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks funding outcomes that correspond usually to the worth and yield efficiency of the NASDAQ Biotechnology Index (the Index). The Index incorporates securities of NASDAQ listed corporations which are categorised in response to the Trade Classification Benchmark as both biotechnology or prescribed drugs, which additionally meet different eligibility standards decided by NASDAQ.
Featured Articles
Obtain Information & Rankings for iShares Biotechnology ETF Day by day – Enter your e-mail tackle under to obtain a concise each day abstract of the most recent information and analysts’ scores for iShares Biotechnology ETF and associated corporations with MarketBeat.com’s FREE each day e-mail publication.
